Copyright Reports & Markets. All rights reserved.

Global Inflammatory Bowel Disease Therapy Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Inflammatory Bowel Disease Therapy Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Ulcerative Colitis
      • 1.4.3 Crohns Disease
      • 1.4.4 Others
    • 1.5 Market by Application
      • 1.5.1 Global Inflammatory Bowel Disease Therapy Market Share by Application (2019-2025)
      • 1.5.2 Hospital
      • 1.5.3 Medical Research Organization
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Inflammatory Bowel Disease Therapy Market Size
    • 2.2 Inflammatory Bowel Disease Therapy Growth Trends by Regions
      • 2.2.1 Inflammatory Bowel Disease Therapy Market Size by Regions (2019-2025)
      • 2.2.2 Inflammatory Bowel Disease Therapy Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Inflammatory Bowel Disease Therapy Market Size by by Players
      • 3.1.1 Global Inflammatory Bowel Disease Therapy Revenue by by Players (2014-2019)
      • 3.1.2 Global Inflammatory Bowel Disease Therapy Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Inflammatory Bowel Disease Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.2 Inflammatory Bowel Disease Therapy Key Players Head office and Area Served
    • 3.3 Key Players Inflammatory Bowel Disease Therapy Product/Solution/Service
    • 3.4 Date of Enter into Inflammatory Bowel Disease Therapy Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Inflammatory Bowel Disease Therapy Market Size by Type (2014-2019)
    • 4.2 Global Inflammatory Bowel Disease Therapy Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Inflammatory Bowel Disease Therapy Market Size (2014-2019)
    • 5.2 Inflammatory Bowel Disease Therapy Key Players in North America
    • 5.3 North America Inflammatory Bowel Disease Therapy Market Size by Type
    • 5.4 North America Inflammatory Bowel Disease Therapy Market Size by Application

    6 Europe

    • 6.1 Europe Inflammatory Bowel Disease Therapy Market Size (2014-2019)
    • 6.2 Inflammatory Bowel Disease Therapy Key Players in Europe
    • 6.3 Europe Inflammatory Bowel Disease Therapy Market Size by Type
    • 6.4 Europe Inflammatory Bowel Disease Therapy Market Size by Application

    7 China

    • 7.1 China Inflammatory Bowel Disease Therapy Market Size (2014-2019)
    • 7.2 Inflammatory Bowel Disease Therapy Key Players in China
    • 7.3 China Inflammatory Bowel Disease Therapy Market Size by Type
    • 7.4 China Inflammatory Bowel Disease Therapy Market Size by Application

    8 Japan

    • 8.1 Japan Inflammatory Bowel Disease Therapy Market Size (2014-2019)
    • 8.2 Inflammatory Bowel Disease Therapy Key Players in Japan
    • 8.3 Japan Inflammatory Bowel Disease Therapy Market Size by Type
    • 8.4 Japan Inflammatory Bowel Disease Therapy Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Inflammatory Bowel Disease Therapy Market Size (2014-2019)
    • 9.2 Inflammatory Bowel Disease Therapy Key Players in Southeast Asia
    • 9.3 Southeast Asia Inflammatory Bowel Disease Therapy Market Size by Type
    • 9.4 Southeast Asia Inflammatory Bowel Disease Therapy Market Size by Application

    10 India

    • 10.1 India Inflammatory Bowel Disease Therapy Market Size (2014-2019)
    • 10.2 Inflammatory Bowel Disease Therapy Key Players in India
    • 10.3 India Inflammatory Bowel Disease Therapy Market Size by Type
    • 10.4 India Inflammatory Bowel Disease Therapy Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Inflammatory Bowel Disease Therapy Market Size (2014-2019)
    • 11.2 Inflammatory Bowel Disease Therapy Key Players in Central & South America
    • 11.3 Central & South America Inflammatory Bowel Disease Therapy Market Size by Type
    • 11.4 Central & South America Inflammatory Bowel Disease Therapy Market Size by Application

    12 International Players Profiles

    • 12.1 Johnson & Johnson
      • 12.1.1 Johnson & Johnson Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Inflammatory Bowel Disease Therapy Introduction
      • 12.1.4 Johnson & Johnson Revenue in Inflammatory Bowel Disease Therapy Business (2014-2019))
      • 12.1.5 Johnson & Johnson Recent Development
    • 12.2 AbbVie
      • 12.2.1 AbbVie Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Inflammatory Bowel Disease Therapy Introduction
      • 12.2.4 AbbVie Revenue in Inflammatory Bowel Disease Therapy Business (2014-2019)
      • 12.2.5 AbbVie Recent Development
    • 12.3 Takeda Pharmaceutical Company
      • 12.3.1 Takeda Pharmaceutical Company Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Inflammatory Bowel Disease Therapy Introduction
      • 12.3.4 Takeda Pharmaceutical Company Revenue in Inflammatory Bowel Disease Therapy Business (2014-2019)
      • 12.3.5 Takeda Pharmaceutical Company Recent Development
    • 12.4 Abbott
      • 12.4.1 Abbott Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Inflammatory Bowel Disease Therapy Introduction
      • 12.4.4 Abbott Revenue in Inflammatory Bowel Disease Therapy Business (2014-2019)
      • 12.4.5 Abbott Recent Development
    • 12.5 Celgene Corporation
      • 12.5.1 Celgene Corporation Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Inflammatory Bowel Disease Therapy Introduction
      • 12.5.4 Celgene Corporation Revenue in Inflammatory Bowel Disease Therapy Business (2014-2019)
      • 12.5.5 Celgene Corporation Recent Development
    • 12.6 Innovate Biopharma
      • 12.6.1 Innovate Biopharma Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Inflammatory Bowel Disease Therapy Introduction
      • 12.6.4 Innovate Biopharma Revenue in Inflammatory Bowel Disease Therapy Business (2014-2019)
      • 12.6.5 Innovate Biopharma Recent Development
    • 12.7 Cosmo Pharmaceuticals
      • 12.7.1 Cosmo Pharmaceuticals Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Inflammatory Bowel Disease Therapy Introduction
      • 12.7.4 Cosmo Pharmaceuticals Revenue in Inflammatory Bowel Disease Therapy Business (2014-2019)
      • 12.7.5 Cosmo Pharmaceuticals Recent Development
    • 12.8 Gilead Sciences
      • 12.8.1 Gilead Sciences Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Inflammatory Bowel Disease Therapy Introduction
      • 12.8.4 Gilead Sciences Revenue in Inflammatory Bowel Disease Therapy Business (2014-2019)
      • 12.8.5 Gilead Sciences Recent Development
    • 12.9 Pfizer
      • 12.9.1 Pfizer Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Inflammatory Bowel Disease Therapy Introduction
      • 12.9.4 Pfizer Revenue in Inflammatory Bowel Disease Therapy Business (2014-2019)
      • 12.9.5 Pfizer Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Inflammatory bowel disease (IBD) is a chronic inflammatory bowel disease of unknown etiology, mainly including ulcerative colitis (UC) and crohn's disease (CD).The etiology may include environmental, infectious, immune and genetic factors.Because the etiology of inflammatory bowel disease is not clear, clinical symptoms are not specific, easy to be confused with other diseases, so the diagnosis is more difficult.Once misdiagnosis is caused by mistreatment, the result is mild but not cured, serious is life-threatening.The diagnosis of inflammatory bowel disease mainly includes the collection of clinical history, colonoscopy, imaging and mucosal histology.
      In 2018, the global Inflammatory Bowel Disease Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Inflammatory Bowel Disease Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Inflammatory Bowel Disease Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Johnson & Johnson
      AbbVie
      Takeda Pharmaceutical Company
      Abbott
      Celgene Corporation
      Innovate Biopharma
      Cosmo Pharmaceuticals
      Gilead Sciences
      Pfizer

      Market segment by Type, the product can be split into
      Ulcerative Colitis
      Crohns Disease
      Others

      Market segment by Application, split into
      Hospital
      Medical Research Organization
      Other

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Inflammatory Bowel Disease Therapy status, future forecast, growth opportunity, key market and key players.
      To present the Inflammatory Bowel Disease Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Inflammatory Bowel Disease Therapy are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now